ask="4.69"
ask_size="200"
average_daily_volume="120173"
bid="3.86"
bid_size="200"
book_value="1.98"
change="+0.05"
change_from_200_day_moving_average="0.07"
change_from_50_day_moving_average="0.56"
change_from_52_week_high="-3.86"
change_From_52_week_low="1.07"
change_in_percent="+1.18%"
close="4.29"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.39"
ebitda="-35.85M"
eps_estimate_current_year="-2.28"
eps_estimate_next_quarter="-0.50"
eps_estimate_next_year="-2.14"
ex_dividend_date="N/A"
float_shares="8580000"
high="4.48"
high_52_weeks="8.15"
last_trade_date="1/13/2017"
last_trade_price="4.29"
last_trade_size="300"
last_trade_time="4:00pm"
low="4.21"
low_52_weeks="3.22"
market_capitalization="80.02M"
moving_average_200_day="4.22"
moving_average_50_day="3.73"
name="Catabasis Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="17.00"
open="4.21"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+1.73%"
percent_change_from_50_day_moving_average="+15.05%"
percent_change_from_52_week_high="-47.36%"
percent_change_from_52_week_low="+33.23%"
previous_close="4.24"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.14"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18652000"
short_ratio="2.34"
stock_exchange="NGM"
symbol="CATB"
volume="77449"
weeks_range_52="3.22 - 8.15"
